One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Aims+Scope/Editorial Board/ Publication information
doi : 10.1016/S0167-8140(24)04335-4
Volume 202, January 2025, 110673
Driving innovation in radiation oncology in a changing world: The Green Journal’s roadmap for the next decade
Boron neutron capture therapy for cutaneous angiosarcoma and malignant melanoma: First in-human phase I clinical trial
Protocol compliance in a multicentric phase III trial investigating scheduled adaptive radiotherapy and dose painting in head and neck cancer
Climate impact of early-stage NSCLC treatment: A comparison between radiotherapy and surgery using Life Cycle Assessment
Dose constraints in breast cancer radiotherapy. A critical review
Population based audit of heart radiation doses in 6925 high-risk breast cancer patients from the Danish breast cancer group RT Nation study
Efficacy of radiotherapy for bone metastasis in breast cancer patients treated with cyclin-dependent kinase 4/6 inhibitors
Patient reported fatigue after proton therapy for malignant brain tumours – Is there a relation between radiation dose and brain structures?
Variable-RBE-induced NTCP predictions for various side-effects following proton therapy for brain tumors – Identification of high-risk patients and risk mitigation
ESTRO-EANO guideline on target delineation and radiotherapy for IDH-mutant WHO CNS grade 2 and 3 diffuse glioma
Evaluation of radiation induced brain injury in nasopharyngeal carcinoma patients based on multi-parameter quantitative MRI: A prospective longitudinal study
An update to the American Radium Society’s appropriate use criteria of lower grade gliomas: Integration of IDH inhibitors
International collaboration of neoadjuvant stereotactic radiosurgery for brain metastases: The INTERNEO individual patient data pooled analysis
Evaluating and reporting LET and RBE-weighted dose in proton therapy for glioma – The Dutch approach
Comparison of stereotactic body radiotherapy and transcatheter arterial chemoembolization for hepatocellular carcinoma: Systematic review and meta�analysis
Correlation of dynamic blood dose with clinical outcomes in radiotherapy for head-and-neck cancer
Long-term trends in the burden of nasopharyngeal carcinoma in China: A comprehensive analysis from 1990 to 2021 and projections to 2030 based on the global burden of disease study 2021
Patterns of loco-regional progression and patient outcomes after definitive-dose radiation therapy for anaplastic thyroid cancer
Optimum radiation dose for palliation in head and neck squamous cell carcinoma (OpRAH) – A phase 3 randomized controlled trial
Optimizing palliative radiation: Beyond dose escalation in advanced head and neck squamous cell carcinoma
Response to “Optimizing palliative radiation: Beyond dose escalation in advanced head and neck squamous cell carcinoma�
Risk factors of level Ib lymph node metastasis and clinical outcome of its selectively prophylactic irradiation in nasopharyngeal carcinoma: A real-world study
A critical reflection of radiotherapy on osseous free flaps in mandibular segmental resection and immediate reconstruction in locally advanced oral squamous cell carcinoma: A cohort study
Prevalence of depressive and anxiety symptoms in patients with head and neck cancer undergoing radiotherapy: A systematic review and meta-analysis of longitudinal studies
Intensity-modulated proton therapy versus volumetric-modulated ARC therapy in patients with nasopharyngeal carcinoma: A long-term, multicenter cohort study
Toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer: A secondary analysis of the LUSTRE randomized trial
Role of consolidative thoracic and prophylactic cranial radiation in extensive stage small cell lung cancer in chemo-immunotherapy era
Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer
Prostate-specific antigen kinetics after stereotactic body radiotherapy for localized prostate cancer: A scoping review and meta-analysis
Radiation therapy for stage IIA/IIB seminomas: Back to the future?
Hypofractionated accelerated radiation dose-painting (HARD) improves outcomes in unresected soft-tissue sarcoma
Risk and survival outcomes of secondary pelvic neoplasm after radiotherapy in female patients with genital neoplasms: A large Population-Based cohort study
Measuring the impact of treatment on memory functions in pediatric posterior fossa tumor survivors using diffusion tensor imaging
Identifying paediatric patients at risk of severe hearing impairment after treatment for malignancies of the H&N/CNS with proton therapy
Locoregional control in high-risk neuroblastoma using highly-conformal image-guided radiotherapy, with reduced margins and a boost dose for residual lesions
Achieving accurate prostate auto-segmentation on CT in the absence of MR imaging
Dose calculation accuracy of a new high-performance ring-gantry CBCT imaging system for prostate and lung cancer patients
Quality assurance of internal mammary node irradiation in the DBCG IMN2 study
Deep learning-based multiple-CT optimization: An adaptive treatment planning approach to account for anatomical changes in intensity-modulated proton therapy for head and neck cancers
Dosimetric impact of sparing base of heart on organ at risk doses during lung radiotherapy
EGCG protects intestines of mice and pelvic cancer patients against radiation injury via the gut microbiota/D-tagatose/AMPK axis
A novel lineage-tracing tool reveals that hypoxic tumor cells drive tumor relapse after radiotherapy
A metabolic switch to the pentose-phosphate pathway induces radiation resistance in pancreatic cancer
Altering fractionation during radiation overcomes radio-resistance in patient-derived glioblastoma cells assessed using a novel longitudinal radiation cytotoxicity assay
Knowledge-based planning, multicriteria optimization, and plan scorecards: A winning combination
Knowledge-based planning for fully automated radiation therapy treatment planning of 10 different cancer sites
Auto-contouring of cardiac substructures for Stereotactic arrhythmia radioablation (STAR): A STOPSTORM.eu consortium study
A feasibility study of dose-band prediction in radiation therapy: Predicting a spectrum of plan dose
Automated segmentation in planning-CT for breast cancer radiotherapy: A review of recent advances
Proton FLASH-arc therapy (PFAT): A feasibility study for meeting FLASH dose-rate requirements in the clinic
Effects of photobiomodulation therapy for acute radiation dermatitis in patients with cancer: A systematic review and meta‑analysis of real-world evidence
What is the incidence and non-union rate of radiation-associated fractures? – A systematic review of the literature
Ongoing prospective studies on reirradiation: A systematic review of a clinical trials database
A systematic review and meta-analysis on the impact of institutional peer review in radiation oncology
The indispensable role of peer review in modern radiation oncology
Evaluating ChatGPT’s competency in radiation oncology: A comprehensive assessment across clinical scenarios
Consistency in reirradiation scenarios: Terminology, tissue recovery in calculations, units and reporting
Comment on FET PET-based target volume delineation for the radiotherapy of glioblastoma: A pictorial guide to help overcome methodological pitfalls
Comment on “Analysis of re-recurrent rectal cancer after curative treatment of locally recurrent rectal cancer�
“Cardiovascular toxicities of radiotherapy: From practical issues to new perspectives radiotherapy and Oncology� Marianne C. Aznar, Jutta Bergler-Klein, Giuseppe Boriani, David, J. Cutter, Coen Hurkmans, Mario Levis, Teresa Lopez-Fernandez, Alexander R. Lyon, Maja V. Maraldo. Radiother Oncol. 2024 Aug:197:110336. https://doi.org/10.1016/j.radonc.2024.110336.Epub 2024 may 24
Commentary on Bentsen et al.’s study of rib fracture risk after stereotactic body radiotherapy
Response to commentary on “Cumulative rib fracture risk after stereotactic body radiotherapy in patients with localized non-small cell lung cancer� by Tugcu et al
